FDA pushes deadline on pharma supply chain law; feds fine Medicare Advantage plans

Taking stock of the drug industry, from the lab to the medicine chest

August 28, 2023 Check out STAT+

Sponsored By

By Ed Silverman Pharmalot Columnist, Senior Writer

Manuel Balce Ceneta/AP STAT+ | FDA delays enforcement of a pharmaceutical supply chain law to stop counterfeit drugs As a Nov. 27, deadline for compliance approached, concern had grown that too many companies are not fully prepared to comply with the law. By Ed Silverman STAT+ | Feds fine Medicare Advantage plans for overcharging their members Medicare Advantage insurers have started to be penalized for faulty technology systems that lead to people paying more than they should be. By Bob Herman STAT+ | What do new weight loss drugs mean for the future of bariatric surgery? New weight loss drugs have captured the public's imagination but also raised existential questions about the future of bariatric surgery. By Simar Bajaj Screen grab via ProMED ProMED issues ultimatum to striking moderators, as questions about site's future persist The site's striking moderators were told to return to work on Friday, or they will be considered to have "moved on." By Helen Branswell

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Pharmalot? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2023, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser